Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why.
#tesla #ai #meta #elonmusk #ftc #coffee
Listen to the podcast here: https://link.chtbl.com/MBD
Follow us on Twitter: https://twitter.com/mbdailyshow
Follow us on Instagram: https://www.instagram.com/mbdailyshow/
Follow us on TikTok: http://www.tiktok.com/@mbdailyshow
Sign up for the Morning Brew Newsletter: https://www.morningbrew.com/daily/subscribe?utm_campaign=mbd_yt&utm_medium=multimedia&utm_source=youtube
Morning Brew Daily, a daily talk show that covers the latest news on business, the economy, and everything else, with Neal Freyman and Toby Howell. Witty, informative and everything you need to start your day. Available on all podcasting platforms and Youtube.
00:00 - Intro
02:45 - Tesla Earnings
07:00 - FTC Bans Noncompetes
10:25 - Meta AI
14:00 - Miracle Aging Drug
18:00 - Coffee Brewing
21:20 - Pole Vaulter Record